| UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
|
|||||||
|
Fusion Protein:ATP2C2-FTO |
Fusion Protein Summary |
 Fusion gene summary |
| Fusion partner gene information | Fusion gene name: ATP2C2-FTO | FusionPDB ID: 7903 | FusionGDB2.0 ID: 7903 | Hgene | Tgene | Gene symbol | ATP2C2 | FTO | Gene ID | 9914 | 79068 |
| Gene name | ATPase secretory pathway Ca2+ transporting 2 | FTO alpha-ketoglutarate dependent dioxygenase | |
| Synonyms | SPCA2 | ALKBH9|BMIQ14|GDFD | |
| Cytomap | 16q24.1 | 16q12.2 | |
| Type of gene | protein-coding | protein-coding | |
| Description | calcium-transporting ATPase type 2C member 2ATPase 2C2ATPase, Ca++ transporting, type 2C, member 2secretory pathway Ca(2+)-ATPase 2secretory pathway calcium ATPase 2 | alpha-ketoglutarate-dependent dioxygenase FTOAlkB homolog 9U6 small nuclear RNA (2'-O-methyladenosine-N(6)-)-demethylase FTOU6 small nuclear RNA N(6)-methyladenosine-demethylase FTOfat mass and obesity associatedfat mass and obesity-associated protei | |
| Modification date | 20200320 | 20200329 | |
| UniProtAcc | O75185 | Q9C0B1 | |
| Ensembl transtripts involved in fusion gene | ENST ids | ENST00000262429, ENST00000416219, ENST00000420010, | ENST00000472835, ENST00000394647, ENST00000431610, ENST00000460382, ENST00000463855, ENST00000471389, |
| Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 10 X 6 X 6=360 | 12 X 10 X 7=840 |
| # samples | 12 | 15 | |
| ** MAII score | log2(12/360*10)=-1.58496250072116 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(15/840*10)=-2.48542682717024 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context (manual curation of fusion genes in FusionPDB) | PubMed: ATP2C2 [Title/Abstract] AND FTO [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | ATP2C2(84432215)-FTO(53967896), # samples:1 ATP2C2(84432215)-FTO(53967897), # samples:1 | ||
| Anticipated loss of major functional domain due to fusion event. | ATP2C2-FTO seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. ATP2C2-FTO seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. ATP2C2-FTO seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. ATP2C2-FTO seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. | ||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Tgene | FTO | GO:0006307 | DNA dealkylation involved in DNA repair | 18775698|20376003 |
| Tgene | FTO | GO:0035552 | oxidative single-stranded DNA demethylation | 18775698|20376003 |
| Tgene | FTO | GO:0035553 | oxidative single-stranded RNA demethylation | 18775698|22002720|25452335|26457839|28002401|30197295 |
| Tgene | FTO | GO:0042245 | RNA repair | 18775698 |
| Tgene | FTO | GO:0061157 | mRNA destabilization | 28002401|30197295 |
| Tgene | FTO | GO:0070989 | oxidative demethylation | 18775698 |
| Tgene | FTO | GO:0080111 | DNA demethylation | 18775698 |
| Fusion gene breakpoints across ATP2C2 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene breakpoints across FTO (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
Top |
Fusion Gene Sample Information |
| Fusion gene information from FusionGDB2.0. |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | STAD | TCGA-CD-8534-01A | ATP2C2 | chr16 | 84432215 | + | FTO | chr16 | 53967897 | + |
| ChimerDB4 | STAD | TCGA-CD-8534 | ATP2C2 | chr16 | 84432215 | + | FTO | chr16 | 53967896 | + |
Top |
Fusion ORF Analysis |
| Fusion information from ORFfinder translation from full-length transcript sequence from FusionPDB. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000262429 | ATP2C2 | chr16 | 84432215 | + | ENST00000471389 | FTO | chr16 | 53967896 | + | 10604 | 299 | 74 | 577 | 167 |
| ENST00000262429 | ATP2C2 | chr16 | 84432215 | + | ENST00000394647 | FTO | chr16 | 53967896 | + | 750 | 299 | 74 | 577 | 167 |
| ENST00000262429 | ATP2C2 | chr16 | 84432215 | + | ENST00000431610 | FTO | chr16 | 53967896 | + | 801 | 299 | 74 | 577 | 167 |
| ENST00000262429 | ATP2C2 | chr16 | 84432215 | + | ENST00000460382 | FTO | chr16 | 53967896 | + | 1650 | 299 | 74 | 577 | 167 |
| ENST00000262429 | ATP2C2 | chr16 | 84432215 | + | ENST00000463855 | FTO | chr16 | 53967896 | + | 3126 | 299 | 74 | 577 | 167 |
| ENST00000416219 | ATP2C2 | chr16 | 84432215 | + | ENST00000471389 | FTO | chr16 | 53967896 | + | 10604 | 299 | 74 | 577 | 167 |
| ENST00000416219 | ATP2C2 | chr16 | 84432215 | + | ENST00000394647 | FTO | chr16 | 53967896 | + | 750 | 299 | 74 | 577 | 167 |
| ENST00000416219 | ATP2C2 | chr16 | 84432215 | + | ENST00000431610 | FTO | chr16 | 53967896 | + | 801 | 299 | 74 | 577 | 167 |
| ENST00000416219 | ATP2C2 | chr16 | 84432215 | + | ENST00000460382 | FTO | chr16 | 53967896 | + | 1650 | 299 | 74 | 577 | 167 |
| ENST00000416219 | ATP2C2 | chr16 | 84432215 | + | ENST00000463855 | FTO | chr16 | 53967896 | + | 3126 | 299 | 74 | 577 | 167 |
| ENST00000262429 | ATP2C2 | chr16 | 84432215 | + | ENST00000471389 | FTO | chr16 | 53967897 | + | 10604 | 299 | 74 | 577 | 167 |
| ENST00000262429 | ATP2C2 | chr16 | 84432215 | + | ENST00000394647 | FTO | chr16 | 53967897 | + | 750 | 299 | 74 | 577 | 167 |
| ENST00000262429 | ATP2C2 | chr16 | 84432215 | + | ENST00000431610 | FTO | chr16 | 53967897 | + | 801 | 299 | 74 | 577 | 167 |
| ENST00000262429 | ATP2C2 | chr16 | 84432215 | + | ENST00000460382 | FTO | chr16 | 53967897 | + | 1650 | 299 | 74 | 577 | 167 |
| ENST00000262429 | ATP2C2 | chr16 | 84432215 | + | ENST00000463855 | FTO | chr16 | 53967897 | + | 3126 | 299 | 74 | 577 | 167 |
| ENST00000416219 | ATP2C2 | chr16 | 84432215 | + | ENST00000471389 | FTO | chr16 | 53967897 | + | 10604 | 299 | 74 | 577 | 167 |
| ENST00000416219 | ATP2C2 | chr16 | 84432215 | + | ENST00000394647 | FTO | chr16 | 53967897 | + | 750 | 299 | 74 | 577 | 167 |
| ENST00000416219 | ATP2C2 | chr16 | 84432215 | + | ENST00000431610 | FTO | chr16 | 53967897 | + | 801 | 299 | 74 | 577 | 167 |
| ENST00000416219 | ATP2C2 | chr16 | 84432215 | + | ENST00000460382 | FTO | chr16 | 53967897 | + | 1650 | 299 | 74 | 577 | 167 |
| ENST00000416219 | ATP2C2 | chr16 | 84432215 | + | ENST00000463855 | FTO | chr16 | 53967897 | + | 3126 | 299 | 74 | 577 | 167 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000262429 | ENST00000471389 | ATP2C2 | chr16 | 84432215 | + | FTO | chr16 | 53967896 | + | 0.002881263 | 0.9971187 |
| ENST00000262429 | ENST00000394647 | ATP2C2 | chr16 | 84432215 | + | FTO | chr16 | 53967896 | + | 0.004049139 | 0.9959508 |
| ENST00000262429 | ENST00000431610 | ATP2C2 | chr16 | 84432215 | + | FTO | chr16 | 53967896 | + | 0.005391473 | 0.9946085 |
| ENST00000262429 | ENST00000460382 | ATP2C2 | chr16 | 84432215 | + | FTO | chr16 | 53967896 | + | 0.003232947 | 0.99676704 |
| ENST00000262429 | ENST00000463855 | ATP2C2 | chr16 | 84432215 | + | FTO | chr16 | 53967896 | + | 0.003872769 | 0.9961273 |
| ENST00000416219 | ENST00000471389 | ATP2C2 | chr16 | 84432215 | + | FTO | chr16 | 53967896 | + | 0.002881263 | 0.9971187 |
| ENST00000416219 | ENST00000394647 | ATP2C2 | chr16 | 84432215 | + | FTO | chr16 | 53967896 | + | 0.004049139 | 0.9959508 |
| ENST00000416219 | ENST00000431610 | ATP2C2 | chr16 | 84432215 | + | FTO | chr16 | 53967896 | + | 0.005391473 | 0.9946085 |
| ENST00000416219 | ENST00000460382 | ATP2C2 | chr16 | 84432215 | + | FTO | chr16 | 53967896 | + | 0.003232947 | 0.99676704 |
| ENST00000416219 | ENST00000463855 | ATP2C2 | chr16 | 84432215 | + | FTO | chr16 | 53967896 | + | 0.003872769 | 0.9961273 |
| ENST00000262429 | ENST00000471389 | ATP2C2 | chr16 | 84432215 | + | FTO | chr16 | 53967897 | + | 0.002881263 | 0.9971187 |
| ENST00000262429 | ENST00000394647 | ATP2C2 | chr16 | 84432215 | + | FTO | chr16 | 53967897 | + | 0.004049139 | 0.9959508 |
| ENST00000262429 | ENST00000431610 | ATP2C2 | chr16 | 84432215 | + | FTO | chr16 | 53967897 | + | 0.005391473 | 0.9946085 |
| ENST00000262429 | ENST00000460382 | ATP2C2 | chr16 | 84432215 | + | FTO | chr16 | 53967897 | + | 0.003232947 | 0.99676704 |
| ENST00000262429 | ENST00000463855 | ATP2C2 | chr16 | 84432215 | + | FTO | chr16 | 53967897 | + | 0.003872769 | 0.9961273 |
| ENST00000416219 | ENST00000471389 | ATP2C2 | chr16 | 84432215 | + | FTO | chr16 | 53967897 | + | 0.002881263 | 0.9971187 |
| ENST00000416219 | ENST00000394647 | ATP2C2 | chr16 | 84432215 | + | FTO | chr16 | 53967897 | + | 0.004049139 | 0.9959508 |
| ENST00000416219 | ENST00000431610 | ATP2C2 | chr16 | 84432215 | + | FTO | chr16 | 53967897 | + | 0.005391473 | 0.9946085 |
| ENST00000416219 | ENST00000460382 | ATP2C2 | chr16 | 84432215 | + | FTO | chr16 | 53967897 | + | 0.003232947 | 0.99676704 |
| ENST00000416219 | ENST00000463855 | ATP2C2 | chr16 | 84432215 | + | FTO | chr16 | 53967897 | + | 0.003872769 | 0.9961273 |
Top |
Fusion Amino Acid Sequences |
| For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >7903_7903_1_ATP2C2-FTO_ATP2C2_chr16_84432215_ENST00000262429_FTO_chr16_53967896_ENST00000394647_length(amino acids)=167AA_BP=75 MRPLTMVEGRVSEFLKKLGFSGGGRQYQALEKDEEEALIDEQSELKAIEKEKKVTALPPKEACKCQKEDLARAFCTNAVLHEVKREGLPV -------------------------------------------------------------- >7903_7903_2_ATP2C2-FTO_ATP2C2_chr16_84432215_ENST00000262429_FTO_chr16_53967896_ENST00000431610_length(amino acids)=167AA_BP=75 MRPLTMVEGRVSEFLKKLGFSGGGRQYQALEKDEEEALIDEQSELKAIEKEKKVTALPPKEACKCQKEDLARAFCTNAVLHEVKREGLPV -------------------------------------------------------------- >7903_7903_3_ATP2C2-FTO_ATP2C2_chr16_84432215_ENST00000262429_FTO_chr16_53967896_ENST00000460382_length(amino acids)=167AA_BP=75 MRPLTMVEGRVSEFLKKLGFSGGGRQYQALEKDEEEALIDEQSELKAIEKEKKVTALPPKEACKCQKEDLARAFCTNAVLHEVKREGLPV -------------------------------------------------------------- >7903_7903_4_ATP2C2-FTO_ATP2C2_chr16_84432215_ENST00000262429_FTO_chr16_53967896_ENST00000463855_length(amino acids)=167AA_BP=75 MRPLTMVEGRVSEFLKKLGFSGGGRQYQALEKDEEEALIDEQSELKAIEKEKKVTALPPKEACKCQKEDLARAFCTNAVLHEVKREGLPV -------------------------------------------------------------- >7903_7903_5_ATP2C2-FTO_ATP2C2_chr16_84432215_ENST00000262429_FTO_chr16_53967896_ENST00000471389_length(amino acids)=167AA_BP=75 MRPLTMVEGRVSEFLKKLGFSGGGRQYQALEKDEEEALIDEQSELKAIEKEKKVTALPPKEACKCQKEDLARAFCTNAVLHEVKREGLPV -------------------------------------------------------------- >7903_7903_6_ATP2C2-FTO_ATP2C2_chr16_84432215_ENST00000262429_FTO_chr16_53967897_ENST00000394647_length(amino acids)=167AA_BP=75 MRPLTMVEGRVSEFLKKLGFSGGGRQYQALEKDEEEALIDEQSELKAIEKEKKVTALPPKEACKCQKEDLARAFCTNAVLHEVKREGLPV -------------------------------------------------------------- >7903_7903_7_ATP2C2-FTO_ATP2C2_chr16_84432215_ENST00000262429_FTO_chr16_53967897_ENST00000431610_length(amino acids)=167AA_BP=75 MRPLTMVEGRVSEFLKKLGFSGGGRQYQALEKDEEEALIDEQSELKAIEKEKKVTALPPKEACKCQKEDLARAFCTNAVLHEVKREGLPV -------------------------------------------------------------- >7903_7903_8_ATP2C2-FTO_ATP2C2_chr16_84432215_ENST00000262429_FTO_chr16_53967897_ENST00000460382_length(amino acids)=167AA_BP=75 MRPLTMVEGRVSEFLKKLGFSGGGRQYQALEKDEEEALIDEQSELKAIEKEKKVTALPPKEACKCQKEDLARAFCTNAVLHEVKREGLPV -------------------------------------------------------------- >7903_7903_9_ATP2C2-FTO_ATP2C2_chr16_84432215_ENST00000262429_FTO_chr16_53967897_ENST00000463855_length(amino acids)=167AA_BP=75 MRPLTMVEGRVSEFLKKLGFSGGGRQYQALEKDEEEALIDEQSELKAIEKEKKVTALPPKEACKCQKEDLARAFCTNAVLHEVKREGLPV -------------------------------------------------------------- >7903_7903_10_ATP2C2-FTO_ATP2C2_chr16_84432215_ENST00000262429_FTO_chr16_53967897_ENST00000471389_length(amino acids)=167AA_BP=75 MRPLTMVEGRVSEFLKKLGFSGGGRQYQALEKDEEEALIDEQSELKAIEKEKKVTALPPKEACKCQKEDLARAFCTNAVLHEVKREGLPV -------------------------------------------------------------- >7903_7903_11_ATP2C2-FTO_ATP2C2_chr16_84432215_ENST00000416219_FTO_chr16_53967896_ENST00000394647_length(amino acids)=167AA_BP=75 MRPLTMVEGRVSEFLKKLGFSGGGRQYQALEKDEEEALIDEQSELKAIEKEKKVTALPPKEACKCQKEDLARAFCTNAVLHEVKREGLPV -------------------------------------------------------------- >7903_7903_12_ATP2C2-FTO_ATP2C2_chr16_84432215_ENST00000416219_FTO_chr16_53967896_ENST00000431610_length(amino acids)=167AA_BP=75 MRPLTMVEGRVSEFLKKLGFSGGGRQYQALEKDEEEALIDEQSELKAIEKEKKVTALPPKEACKCQKEDLARAFCTNAVLHEVKREGLPV -------------------------------------------------------------- >7903_7903_13_ATP2C2-FTO_ATP2C2_chr16_84432215_ENST00000416219_FTO_chr16_53967896_ENST00000460382_length(amino acids)=167AA_BP=75 MRPLTMVEGRVSEFLKKLGFSGGGRQYQALEKDEEEALIDEQSELKAIEKEKKVTALPPKEACKCQKEDLARAFCTNAVLHEVKREGLPV -------------------------------------------------------------- >7903_7903_14_ATP2C2-FTO_ATP2C2_chr16_84432215_ENST00000416219_FTO_chr16_53967896_ENST00000463855_length(amino acids)=167AA_BP=75 MRPLTMVEGRVSEFLKKLGFSGGGRQYQALEKDEEEALIDEQSELKAIEKEKKVTALPPKEACKCQKEDLARAFCTNAVLHEVKREGLPV -------------------------------------------------------------- >7903_7903_15_ATP2C2-FTO_ATP2C2_chr16_84432215_ENST00000416219_FTO_chr16_53967896_ENST00000471389_length(amino acids)=167AA_BP=75 MRPLTMVEGRVSEFLKKLGFSGGGRQYQALEKDEEEALIDEQSELKAIEKEKKVTALPPKEACKCQKEDLARAFCTNAVLHEVKREGLPV -------------------------------------------------------------- >7903_7903_16_ATP2C2-FTO_ATP2C2_chr16_84432215_ENST00000416219_FTO_chr16_53967897_ENST00000394647_length(amino acids)=167AA_BP=75 MRPLTMVEGRVSEFLKKLGFSGGGRQYQALEKDEEEALIDEQSELKAIEKEKKVTALPPKEACKCQKEDLARAFCTNAVLHEVKREGLPV -------------------------------------------------------------- >7903_7903_17_ATP2C2-FTO_ATP2C2_chr16_84432215_ENST00000416219_FTO_chr16_53967897_ENST00000431610_length(amino acids)=167AA_BP=75 MRPLTMVEGRVSEFLKKLGFSGGGRQYQALEKDEEEALIDEQSELKAIEKEKKVTALPPKEACKCQKEDLARAFCTNAVLHEVKREGLPV -------------------------------------------------------------- >7903_7903_18_ATP2C2-FTO_ATP2C2_chr16_84432215_ENST00000416219_FTO_chr16_53967897_ENST00000460382_length(amino acids)=167AA_BP=75 MRPLTMVEGRVSEFLKKLGFSGGGRQYQALEKDEEEALIDEQSELKAIEKEKKVTALPPKEACKCQKEDLARAFCTNAVLHEVKREGLPV -------------------------------------------------------------- >7903_7903_19_ATP2C2-FTO_ATP2C2_chr16_84432215_ENST00000416219_FTO_chr16_53967897_ENST00000463855_length(amino acids)=167AA_BP=75 MRPLTMVEGRVSEFLKKLGFSGGGRQYQALEKDEEEALIDEQSELKAIEKEKKVTALPPKEACKCQKEDLARAFCTNAVLHEVKREGLPV -------------------------------------------------------------- >7903_7903_20_ATP2C2-FTO_ATP2C2_chr16_84432215_ENST00000416219_FTO_chr16_53967897_ENST00000471389_length(amino acids)=167AA_BP=75 MRPLTMVEGRVSEFLKKLGFSGGGRQYQALEKDEEEALIDEQSELKAIEKEKKVTALPPKEACKCQKEDLARAFCTNAVLHEVKREGLPV -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr16:84432215/chr16:53967896) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| ATP2C2 | FTO |
| FUNCTION: This magnesium-dependent enzyme catalyzes the hydrolysis of ATP coupled with the transport of calcium. {ECO:0000250}. | FUNCTION: RNA demethylase that mediates oxidative demethylation of different RNA species, such as mRNAs, tRNAs and snRNAs, and acts as a regulator of fat mass, adipogenesis and energy homeostasis (PubMed:22002720, PubMed:26458103, PubMed:28002401, PubMed:30197295, PubMed:26457839, PubMed:25452335). Specifically demethylates N(6)-methyladenosine (m6A) RNA, the most prevalent internal modification of messenger RNA (mRNA) in higher eukaryotes (PubMed:22002720, PubMed:26458103, PubMed:30197295, PubMed:26457839, PubMed:25452335). M6A demethylation by FTO affects mRNA expression and stability (PubMed:30197295). Also able to demethylate m6A in U6 small nuclear RNA (snRNA) (PubMed:30197295). Mediates demethylation of N(6),2'-O-dimethyladenosine cap (m6A(m)), by demethylating the N(6)-methyladenosine at the second transcribed position of mRNAs and U6 snRNA (PubMed:28002401, PubMed:30197295). Demethylation of m6A(m) in the 5'-cap by FTO affects mRNA stability by promoting susceptibility to decapping (PubMed:28002401). Also acts as a tRNA demethylase by removing N(1)-methyladenine from various tRNAs (PubMed:30197295). Has no activity towards 1-methylguanine (PubMed:20376003). Has no detectable activity towards double-stranded DNA (PubMed:20376003). Also able to repair alkylated DNA and RNA by oxidative demethylation: demethylates single-stranded RNA containing 3-methyluracil, single-stranded DNA containing 3-methylthymine and has low demethylase activity towards single-stranded DNA containing 1-methyladenine or 3-methylcytosine (PubMed:18775698, PubMed:20376003). Ability to repair alkylated DNA and RNA is however unsure in vivo (PubMed:18775698, PubMed:20376003). Involved in the regulation of fat mass, adipogenesis and body weight, thereby contributing to the regulation of body size and body fat accumulation (PubMed:18775698, PubMed:20376003). Involved in the regulation of thermogenesis and the control of adipocyte differentiation into brown or white fat cells (PubMed:26287746). Regulates activity of the dopaminergic midbrain circuitry via its ability to demethylate m6A in mRNAs (By similarity). Plays an oncogenic role in a number of acute myeloid leukemias by enhancing leukemic oncogene-mediated cell transformation: acts by mediating m6A demethylation of target transcripts such as MYC, CEBPA, ASB2 and RARA, leading to promote their expression (PubMed:28017614, PubMed:29249359). {ECO:0000250|UniProtKB:Q8BGW1, ECO:0000269|PubMed:18775698, ECO:0000269|PubMed:20376003, ECO:0000269|PubMed:22002720, ECO:0000269|PubMed:25452335, ECO:0000269|PubMed:26287746, ECO:0000269|PubMed:26457839, ECO:0000269|PubMed:26458103, ECO:0000269|PubMed:28002401, ECO:0000269|PubMed:28017614, ECO:0000269|PubMed:29249359, ECO:0000269|PubMed:30197295}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - Retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Tgene | FTO | chr16:84432215 | chr16:53967896 | ENST00000431610 | 2 | 5 | 213_224 | 14.0 | 107.0 | Region | Loop L1%3B predicted to block binding of double-stranded DNA or RNA | |
| Tgene | FTO | chr16:84432215 | chr16:53967896 | ENST00000431610 | 2 | 5 | 231_234 | 14.0 | 107.0 | Region | Substrate binding | |
| Tgene | FTO | chr16:84432215 | chr16:53967896 | ENST00000431610 | 2 | 5 | 316_318 | 14.0 | 107.0 | Region | Alpha-ketoglutarate binding | |
| Tgene | FTO | chr16:84432215 | chr16:53967896 | ENST00000431610 | 2 | 5 | 32_327 | 14.0 | 107.0 | Region | Fe2OG dioxygenase domain | |
| Tgene | FTO | chr16:84432215 | chr16:53967896 | ENST00000460382 | 1 | 4 | 213_224 | 14.0 | 107.0 | Region | Loop L1%3B predicted to block binding of double-stranded DNA or RNA | |
| Tgene | FTO | chr16:84432215 | chr16:53967896 | ENST00000460382 | 1 | 4 | 231_234 | 14.0 | 107.0 | Region | Substrate binding | |
| Tgene | FTO | chr16:84432215 | chr16:53967896 | ENST00000460382 | 1 | 4 | 316_318 | 14.0 | 107.0 | Region | Alpha-ketoglutarate binding | |
| Tgene | FTO | chr16:84432215 | chr16:53967896 | ENST00000460382 | 1 | 4 | 32_327 | 14.0 | 107.0 | Region | Fe2OG dioxygenase domain | |
| Tgene | FTO | chr16:84432215 | chr16:53967896 | ENST00000463855 | 0 | 3 | 213_224 | 35.0 | 128.0 | Region | Loop L1%3B predicted to block binding of double-stranded DNA or RNA | |
| Tgene | FTO | chr16:84432215 | chr16:53967896 | ENST00000463855 | 0 | 3 | 231_234 | 35.0 | 128.0 | Region | Substrate binding | |
| Tgene | FTO | chr16:84432215 | chr16:53967896 | ENST00000463855 | 0 | 3 | 316_318 | 35.0 | 128.0 | Region | Alpha-ketoglutarate binding | |
| Tgene | FTO | chr16:84432215 | chr16:53967896 | ENST00000463855 | 0 | 3 | 32_327 | 35.0 | 128.0 | Region | Fe2OG dioxygenase domain | |
| Tgene | FTO | chr16:84432215 | chr16:53967897 | ENST00000431610 | 2 | 5 | 213_224 | 14.0 | 107.0 | Region | Loop L1%3B predicted to block binding of double-stranded DNA or RNA | |
| Tgene | FTO | chr16:84432215 | chr16:53967897 | ENST00000431610 | 2 | 5 | 231_234 | 14.0 | 107.0 | Region | Substrate binding | |
| Tgene | FTO | chr16:84432215 | chr16:53967897 | ENST00000431610 | 2 | 5 | 316_318 | 14.0 | 107.0 | Region | Alpha-ketoglutarate binding | |
| Tgene | FTO | chr16:84432215 | chr16:53967897 | ENST00000431610 | 2 | 5 | 32_327 | 14.0 | 107.0 | Region | Fe2OG dioxygenase domain | |
| Tgene | FTO | chr16:84432215 | chr16:53967897 | ENST00000460382 | 1 | 4 | 213_224 | 14.0 | 107.0 | Region | Loop L1%3B predicted to block binding of double-stranded DNA or RNA | |
| Tgene | FTO | chr16:84432215 | chr16:53967897 | ENST00000460382 | 1 | 4 | 231_234 | 14.0 | 107.0 | Region | Substrate binding | |
| Tgene | FTO | chr16:84432215 | chr16:53967897 | ENST00000460382 | 1 | 4 | 316_318 | 14.0 | 107.0 | Region | Alpha-ketoglutarate binding | |
| Tgene | FTO | chr16:84432215 | chr16:53967897 | ENST00000460382 | 1 | 4 | 32_327 | 14.0 | 107.0 | Region | Fe2OG dioxygenase domain | |
| Tgene | FTO | chr16:84432215 | chr16:53967897 | ENST00000463855 | 0 | 3 | 213_224 | 35.0 | 128.0 | Region | Loop L1%3B predicted to block binding of double-stranded DNA or RNA | |
| Tgene | FTO | chr16:84432215 | chr16:53967897 | ENST00000463855 | 0 | 3 | 231_234 | 35.0 | 128.0 | Region | Substrate binding | |
| Tgene | FTO | chr16:84432215 | chr16:53967897 | ENST00000463855 | 0 | 3 | 316_318 | 35.0 | 128.0 | Region | Alpha-ketoglutarate binding | |
| Tgene | FTO | chr16:84432215 | chr16:53967897 | ENST00000463855 | 0 | 3 | 32_327 | 35.0 | 128.0 | Region | Fe2OG dioxygenase domain |
| - Not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | ATP2C2 | chr16:84432215 | chr16:53967896 | ENST00000262429 | + | 2 | 27 | 114_119 | 70.0 | 947.0 | Compositional bias | Note=Poly-Leu |
| Hgene | ATP2C2 | chr16:84432215 | chr16:53967897 | ENST00000262429 | + | 2 | 27 | 114_119 | 70.0 | 947.0 | Compositional bias | Note=Poly-Leu |
| Hgene | ATP2C2 | chr16:84432215 | chr16:53967896 | ENST00000262429 | + | 2 | 27 | 128_129 | 70.0 | 947.0 | Topological domain | Extracellular |
| Hgene | ATP2C2 | chr16:84432215 | chr16:53967896 | ENST00000262429 | + | 2 | 27 | 151_231 | 70.0 | 947.0 | Topological domain | Cytoplasmic |
| Hgene | ATP2C2 | chr16:84432215 | chr16:53967896 | ENST00000262429 | + | 2 | 27 | 1_106 | 70.0 | 947.0 | Topological domain | Cytoplasmic |
| Hgene | ATP2C2 | chr16:84432215 | chr16:53967896 | ENST00000262429 | + | 2 | 27 | 253_293 | 70.0 | 947.0 | Topological domain | Extracellular |
| Hgene | ATP2C2 | chr16:84432215 | chr16:53967896 | ENST00000262429 | + | 2 | 27 | 315_331 | 70.0 | 947.0 | Topological domain | Cytoplasmic |
| Hgene | ATP2C2 | chr16:84432215 | chr16:53967896 | ENST00000262429 | + | 2 | 27 | 353_750 | 70.0 | 947.0 | Topological domain | Extracellular |
| Hgene | ATP2C2 | chr16:84432215 | chr16:53967896 | ENST00000262429 | + | 2 | 27 | 772_804 | 70.0 | 947.0 | Topological domain | Cytoplasmic |
| Hgene | ATP2C2 | chr16:84432215 | chr16:53967896 | ENST00000262429 | + | 2 | 27 | 826_837 | 70.0 | 947.0 | Topological domain | Extracellular |
| Hgene | ATP2C2 | chr16:84432215 | chr16:53967896 | ENST00000262429 | + | 2 | 27 | 856_874 | 70.0 | 947.0 | Topological domain | Cytoplasmic |
| Hgene | ATP2C2 | chr16:84432215 | chr16:53967896 | ENST00000262429 | + | 2 | 27 | 896_905 | 70.0 | 947.0 | Topological domain | Extracellular |
| Hgene | ATP2C2 | chr16:84432215 | chr16:53967896 | ENST00000262429 | + | 2 | 27 | 927_946 | 70.0 | 947.0 | Topological domain | Cytoplasmic |
| Hgene | ATP2C2 | chr16:84432215 | chr16:53967897 | ENST00000262429 | + | 2 | 27 | 128_129 | 70.0 | 947.0 | Topological domain | Extracellular |
| Hgene | ATP2C2 | chr16:84432215 | chr16:53967897 | ENST00000262429 | + | 2 | 27 | 151_231 | 70.0 | 947.0 | Topological domain | Cytoplasmic |
| Hgene | ATP2C2 | chr16:84432215 | chr16:53967897 | ENST00000262429 | + | 2 | 27 | 1_106 | 70.0 | 947.0 | Topological domain | Cytoplasmic |
| Hgene | ATP2C2 | chr16:84432215 | chr16:53967897 | ENST00000262429 | + | 2 | 27 | 253_293 | 70.0 | 947.0 | Topological domain | Extracellular |
| Hgene | ATP2C2 | chr16:84432215 | chr16:53967897 | ENST00000262429 | + | 2 | 27 | 315_331 | 70.0 | 947.0 | Topological domain | Cytoplasmic |
| Hgene | ATP2C2 | chr16:84432215 | chr16:53967897 | ENST00000262429 | + | 2 | 27 | 353_750 | 70.0 | 947.0 | Topological domain | Extracellular |
| Hgene | ATP2C2 | chr16:84432215 | chr16:53967897 | ENST00000262429 | + | 2 | 27 | 772_804 | 70.0 | 947.0 | Topological domain | Cytoplasmic |
| Hgene | ATP2C2 | chr16:84432215 | chr16:53967897 | ENST00000262429 | + | 2 | 27 | 826_837 | 70.0 | 947.0 | Topological domain | Extracellular |
| Hgene | ATP2C2 | chr16:84432215 | chr16:53967897 | ENST00000262429 | + | 2 | 27 | 856_874 | 70.0 | 947.0 | Topological domain | Cytoplasmic |
| Hgene | ATP2C2 | chr16:84432215 | chr16:53967897 | ENST00000262429 | + | 2 | 27 | 896_905 | 70.0 | 947.0 | Topological domain | Extracellular |
| Hgene | ATP2C2 | chr16:84432215 | chr16:53967897 | ENST00000262429 | + | 2 | 27 | 927_946 | 70.0 | 947.0 | Topological domain | Cytoplasmic |
| Hgene | ATP2C2 | chr16:84432215 | chr16:53967896 | ENST00000262429 | + | 2 | 27 | 107_127 | 70.0 | 947.0 | Transmembrane | Helical%3B Name%3D1 |
| Hgene | ATP2C2 | chr16:84432215 | chr16:53967896 | ENST00000262429 | + | 2 | 27 | 130_150 | 70.0 | 947.0 | Transmembrane | Helical%3B Name%3D2 |
| Hgene | ATP2C2 | chr16:84432215 | chr16:53967896 | ENST00000262429 | + | 2 | 27 | 232_252 | 70.0 | 947.0 | Transmembrane | Helical%3B Name%3D3 |
| Hgene | ATP2C2 | chr16:84432215 | chr16:53967896 | ENST00000262429 | + | 2 | 27 | 294_314 | 70.0 | 947.0 | Transmembrane | Helical%3B Name%3D4 |
| Hgene | ATP2C2 | chr16:84432215 | chr16:53967896 | ENST00000262429 | + | 2 | 27 | 332_352 | 70.0 | 947.0 | Transmembrane | Helical%3B Name%3D5 |
| Hgene | ATP2C2 | chr16:84432215 | chr16:53967896 | ENST00000262429 | + | 2 | 27 | 751_771 | 70.0 | 947.0 | Transmembrane | Helical%3B Name%3D6 |
| Hgene | ATP2C2 | chr16:84432215 | chr16:53967896 | ENST00000262429 | + | 2 | 27 | 805_825 | 70.0 | 947.0 | Transmembrane | Helical%3B Name%3D7 |
| Hgene | ATP2C2 | chr16:84432215 | chr16:53967896 | ENST00000262429 | + | 2 | 27 | 838_855 | 70.0 | 947.0 | Transmembrane | Helical%3B Name%3D8 |
| Hgene | ATP2C2 | chr16:84432215 | chr16:53967896 | ENST00000262429 | + | 2 | 27 | 875_895 | 70.0 | 947.0 | Transmembrane | Helical%3B Name%3D9 |
| Hgene | ATP2C2 | chr16:84432215 | chr16:53967896 | ENST00000262429 | + | 2 | 27 | 906_926 | 70.0 | 947.0 | Transmembrane | Helical%3B Name%3D10 |
| Hgene | ATP2C2 | chr16:84432215 | chr16:53967897 | ENST00000262429 | + | 2 | 27 | 107_127 | 70.0 | 947.0 | Transmembrane | Helical%3B Name%3D1 |
| Hgene | ATP2C2 | chr16:84432215 | chr16:53967897 | ENST00000262429 | + | 2 | 27 | 130_150 | 70.0 | 947.0 | Transmembrane | Helical%3B Name%3D2 |
| Hgene | ATP2C2 | chr16:84432215 | chr16:53967897 | ENST00000262429 | + | 2 | 27 | 232_252 | 70.0 | 947.0 | Transmembrane | Helical%3B Name%3D3 |
| Hgene | ATP2C2 | chr16:84432215 | chr16:53967897 | ENST00000262429 | + | 2 | 27 | 294_314 | 70.0 | 947.0 | Transmembrane | Helical%3B Name%3D4 |
| Hgene | ATP2C2 | chr16:84432215 | chr16:53967897 | ENST00000262429 | + | 2 | 27 | 332_352 | 70.0 | 947.0 | Transmembrane | Helical%3B Name%3D5 |
| Hgene | ATP2C2 | chr16:84432215 | chr16:53967897 | ENST00000262429 | + | 2 | 27 | 751_771 | 70.0 | 947.0 | Transmembrane | Helical%3B Name%3D6 |
| Hgene | ATP2C2 | chr16:84432215 | chr16:53967897 | ENST00000262429 | + | 2 | 27 | 805_825 | 70.0 | 947.0 | Transmembrane | Helical%3B Name%3D7 |
| Hgene | ATP2C2 | chr16:84432215 | chr16:53967897 | ENST00000262429 | + | 2 | 27 | 838_855 | 70.0 | 947.0 | Transmembrane | Helical%3B Name%3D8 |
| Hgene | ATP2C2 | chr16:84432215 | chr16:53967897 | ENST00000262429 | + | 2 | 27 | 875_895 | 70.0 | 947.0 | Transmembrane | Helical%3B Name%3D9 |
| Hgene | ATP2C2 | chr16:84432215 | chr16:53967897 | ENST00000262429 | + | 2 | 27 | 906_926 | 70.0 | 947.0 | Transmembrane | Helical%3B Name%3D10 |
| Tgene | FTO | chr16:84432215 | chr16:53967896 | ENST00000471389 | 6 | 9 | 213_224 | 413.0 | 506.0 | Region | Loop L1%3B predicted to block binding of double-stranded DNA or RNA | |
| Tgene | FTO | chr16:84432215 | chr16:53967896 | ENST00000471389 | 6 | 9 | 231_234 | 413.0 | 506.0 | Region | Substrate binding | |
| Tgene | FTO | chr16:84432215 | chr16:53967896 | ENST00000471389 | 6 | 9 | 316_318 | 413.0 | 506.0 | Region | Alpha-ketoglutarate binding | |
| Tgene | FTO | chr16:84432215 | chr16:53967896 | ENST00000471389 | 6 | 9 | 32_327 | 413.0 | 506.0 | Region | Fe2OG dioxygenase domain | |
| Tgene | FTO | chr16:84432215 | chr16:53967897 | ENST00000471389 | 6 | 9 | 213_224 | 413.0 | 506.0 | Region | Loop L1%3B predicted to block binding of double-stranded DNA or RNA | |
| Tgene | FTO | chr16:84432215 | chr16:53967897 | ENST00000471389 | 6 | 9 | 231_234 | 413.0 | 506.0 | Region | Substrate binding | |
| Tgene | FTO | chr16:84432215 | chr16:53967897 | ENST00000471389 | 6 | 9 | 316_318 | 413.0 | 506.0 | Region | Alpha-ketoglutarate binding | |
| Tgene | FTO | chr16:84432215 | chr16:53967897 | ENST00000471389 | 6 | 9 | 32_327 | 413.0 | 506.0 | Region | Fe2OG dioxygenase domain |
Top |
Fusion Protein-Protein Interaction |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type from validated records (BIOGRID-3.4.160) |
| Gene | PPI interactors |
| Protein-protein interactors based on sequence similarity (STRING) |
| Gene | STRING network |
| ATP2C2 | |
| FTO |
| - Retained interactions in fusion protein (protein functional feature from UniProt). |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost interactions due to fusion (protein functional feature from UniProt). |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs to ATP2C2-FTO |
| Drugs used for this fusion-positive patient. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
| Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to ATP2C2-FTO |
| Diseases that have this fusion gene. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
| Hgene | Tgene | Disease | Source | PMID |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies